Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
51 participants
OBSERVATIONAL
2019-07-17
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Women of childbearing age will be recruited during their ophthalmologic consultation at the Rothschild Foundation, an OCT-A will be realized and data relating to their medical and ophthalmologic history and their oestro-progestative contraceptive intake will be collected.
The objective is to find an association between retinal vascular density and combined oral contraceptives intake.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases
NCT04451746
The Effect of Oral Contraceptive Pills On Eyes
NCT02841202
The Effect of BMS-986142 on the Pharmacokinetics of a Combined Oral Contraceptive (OC) Containing Ethinyl Estradiol (EE) and Norethindrone Acetate (NET) in Healthy Female Subjects
NCT02832180
A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential
NCT04934696
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no contraceptive intake
OCT-A (optical coherence tomography)
Included patients will have an OCT-A and will be questioned about their medical and ophthalmologic history, and their oestro-progestative contraceptive intake.
combined 1st/2nd generation oral contraceptives intake
OCT-A (optical coherence tomography)
Included patients will have an OCT-A and will be questioned about their medical and ophthalmologic history, and their oestro-progestative contraceptive intake.
3rd/4th generation combined oral contraceptives intake
OCT-A (optical coherence tomography)
Included patients will have an OCT-A and will be questioned about their medical and ophthalmologic history, and their oestro-progestative contraceptive intake.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OCT-A (optical coherence tomography)
Included patients will have an OCT-A and will be questioned about their medical and ophthalmologic history, and their oestro-progestative contraceptive intake.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* for the cases under combined 1st and 2nd generation pills : Estro-progestin contraceptive treatment for at least 6 months
* for the cases under combined 3rd and 2th generation pills: Estro-progestin contraceptive treatment for at least 6 months
Exclusion Criteria
* Ametropia greater than + 3 hyperopia diopters or-3 myopia diopters
* Astigmatism greater than 2 dioptres
* Smoking patient (cigarette or e-cigarette)
* Caffeine intake within 2 hours prior to the OCT-A exam
* Any known retinal pathology
* Antecedent of deep vein thrombosis or deep arterial thrombosis
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation A de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VVR_2019_6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.